Elastrin Therapeutics Inc. is a biotech start-up with a mission to improve quality of life by restoring damaged hardened tissue to healthy reliance. Elastrin Therapeutics was founded by Prof. Naren Vyavahare and Dr. Charles Rice of Clemson University, South Carolina, Douglas Mulhall and Dr. Mirko Stange of Silversky Life Sciences GmbH, Duesseldorf, Germany.
Link Medical is a Northern European full-service clinical CRO providing project management and product development services for the pharmaceutical and medical device industry. In September 2018 LINK Medical Research acquired PCG Clinical Services AB, located in Uppsala. LINK Medical Research has its headquarter in Oslo and additional offices in Stockholm, Malmö, Copenhagen and Berlin.
VAR2 Pharmaceuticals is a privately held biotechnology company engaged in the design and development of proprietary therapeutic proteins targeting cancer-specific carbohydrate structures for multiple cancer indications. The most advanced drug candidate is a recombinant protein conjugated with a toxin.
Ando supports the company in defining their bioanalytical strategy, bioanalytical assay requirements and external partners, thereby, allowing further candidate characterization and toxicological investigations for preparation of the first clinical trial.
Ando spoke about the Importance of Immunogenicity Investigations in Clinical Development of Therapeutic Proteins at a workshop organized by Xendo GmbH, a ProPharma Group company, in collaboration with the biotech syndicate Berlin-Brandenburg bbb.
Y-mAbs Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets based on a range of technologies licensed from Memorial Sloan Kettering Cancer Center under an exclusive world-wide and research collaboration agreement.
PROvendis GmbH is a patent licensing agency for the universities of North Rhine-Westphalia, Germany.